
Nirsevimab slashes RSV hospitalizations in infants by 78% in real-world study
Real-world data from Madrid hospitals show dramatic declines in infant ICU stays, hospital days, and RSV-related admissions after nirsevimab immunization campaign. Study: Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized …